CLRB Earnings Summary: Cellectar Biosciences (CLRB) FY25 net loss narrows 6 hours ago Cellectar Biosciences, Inc. (NASDAQ: CLRB), a biopharmaceutical company engaged in the discovery and development of cancer drugs, reported a narrower…